Responsive microsecond-lifetime photoluminescent probes for analysis of protein kinases and their inhibitors

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1834, Issue 7, 2013, Pages 1330-1335

  Kasari, Marje ^a   Ligi, Kadri ^a   Williams, J A Gareth ^b   Vaasa, Angela ^a   Enkvist, Erki ^a   Viht, Kaido ^a   Pålsson, Lars Olof ^b   Uri, Asko ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Bisubstrate inhibitor; Live cell imaging; Luminescent probe; Protein kinase; Reporter displacement assay; Time gated luminescence

Indexed keywords

FLUORESCENT DYE; FLUOROPHORE; HETEROCYCLE; LYSINE; PEPTIDE FRAGMENT; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; SELENOPHENE; THIOPHENE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXCITATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; ILLUMINATION; MOLECULAR PROBE; PHOSPHORESCENCE; PHOTOLUMINESCENCE; PHOTOLUMINESCENT PROBE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SPECTRAL SENSITIVITY;

ALGORITHMS; ANISOTROPY; BINDING SITES; BINDING, COMPETITIVE; BIOCATALYSIS; FLUORESCENT DYES; KINETICS; LYSINE; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SPECTROPHOTOMETRY; STAUROSPORINE; THIOPHENES; TIME FACTORS;

EID: 84878880872     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2013.02.039     Document Type: Article

References (24)

1. A.L. Hopkins, and C.R. Groom The druggable genome Nat. Rev. Drug Discov. 1 2002 727 730 (Pubitemid 37361545)
2. P. Cohen, and D.R. Alessi Kinase drug discovery - what's next in the field? ACS Chem. Biol. 8 2013 96 104
3. X. Huang Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand J. Biomol. Screen. 8 2003 34 38
4. C.S. Lebakken, S.M. Riddle, U. Singh, W.J. Frazee, H.C. Eliason, Y. Gao, L.J. Reichling, B.D. Marks, and K.W. Vogel Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform J. Biomol. Screen. 14 2009 924 935
5. C.S. Lebakken, L.J. Reichling, J.M. Ellefson, and S.M. Riddle Detection of allosteric kinase inhibitors by displacement of active site probes J. Biomol. Screen. 17 2012 813 821
6. J.L. Mason, C. Spais, J. Husten, E. Prouty, M.S. Albom, S.L. Meyer, M.A. Ator, and T.S. Angeles Comparison of LanthaScreen Eu kinase binding assay and surface plasmon resonance method in elucidating the binding kinetics of focal adhesion kinase inhibitors Assay Drug Dev. Technol. 10 2012 468 475
7. E. Enkvist, A. Vaasa, M. Kasari, M. Kriisa, T. Ivan, K. Ligi, G. Raidaru, and A. Uri Protein-induced long lifetime luminescence of nonmetal probes ACS Chem. Biol. 6 2011 1052 1062
8. D. Lavogina, M. Lust, I. Viil, N. Konig, G. Raidaru, J. Rogozina, E. Enkvist, A. Uri, and D. Bossemeyer Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases J. Med. Chem. 52 2009 308 321
9. C.J. Van Noorden Imaging enzymes at work: metabolic mapping by enzyme histochemistry J. Histochem. Cytochem. 58 2010 481 497
10. L.E. Edgington, M. Verdoes, and M. Bogyo Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes Curr. Opin. Chem. Biol. 15 2011 798 805
11. E. Enkvist, D. Lavogina, G. Raidaru, A. Vaasa, I. Viil, M. Lust, K. Viht, and A. Uri Conjugation of adenosine and hexa-(d-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases J. Med. Chem. 49 2006 7150 7159 (Pubitemid 44886000)
12. D. Lavogina, E. Enkvist, and A. Uri Bisubstrate inhibitors of protein kinases: from principle to practical applications ChemMedChem 5 2010 23 34
13. N.C. Price, and L. Stevens Fundamentals of Enzymology: The Cell and Molecular Biology of Catalytic Proteins 1999 Oxford University Press
14. I.H. Segel Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems 1993 John Wiley & Sons, Inc. New York
15. S.Y. Tetin, and T.L. Hazlett Optical spectroscopy in studies of antibody-hapten interactions Methods 20 2000 341 361 (Pubitemid 32905168)
16. A. Vaasa, I. Viil, E. Enkvist, K. Viht, G. Raidaru, D. Lavogina, and A. Uri High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK Anal. Biochem. 385 2009 85 93
17. A. Uri, M. Lust, A. Vaasa, D. Lavogina, K. Viht, and E. Enkvist Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors Biochim. Biophys. Acta 1804 2010 541 546
18. R.A. Copeland Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists Methods Biochem. Anal. 46 2005 1 265
19. Z. Nikolovska-Coleska, R. Wang, X. Fang, H. Pan, Y. Tomita, P. Li, P.P. Roller, K. Krajewski, N.G. Saito, J.A. Stuckey, and S. Wang Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization Anal. Biochem. 332 2004 261 273 (Pubitemid 39485734)
20. R.Z. Cer, U. Mudunuri, R. Stephens, and F.J. Lebeda IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding Nucleic Acids Res. 37 2009 W441 W445
21. Y. Cheng, and W.H. Prusoff Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
22. A. Vaasa, K. Ligi, S. Mohandessi, E. Enkvist, A. Uri, and L.W. Miller Time-gated luminescence microscopy with responsive nonmetal probes for mapping activity of protein kinases in living cells Chem. Commun. (Camb) 48 2012 8595 8597
23. L. Murphy, A. Congreve, L.O. Palsson, and J.A. Williams The time domain in co-stained cell imaging: time-resolved emission imaging microscopy using a protonatable luminescent iridium complex Chem. Commun. (Camb) 46 2010 8743 8745
24. M. Knapp, C. Bellamacina, J.M. Murray, and D.E. Bussiere Targeting cancer: the challenges and successes of structure-based drug design against the human purinome Curr. Top. Med. Chem. 6 2006 1129 1159 (Pubitemid 44110925)